Portfolio comparison
University of Pennsylvania vs Nektar Therapeutics
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
University of Pennsylvania
Patents indexed
2
Year range
2022
Most recent
2022
biotechpharmaceuticalgene_editing
Top Patents2 enriched
US 11499167· 2022
Engineering Cells to Make Gene Therapy Viruses Using AAVrh.10
US 11357868· 2022
New Adeno-Associated Virus Capsids for Gene Therapy
Activity by Decade
2020s2
Company B
Nektar Therapeutics
Patents indexed
1
Year range
2007
Most recent
2007
biotechpharmaceuticalmaterials
Top Patents1 enriched
US RE39497· 2007
How to Store Fragile Biological Materials Without Refrigeration
Activity by Decade
2000s1
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.